(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on new National Health Expenditure (NHE) data by the Centers for Medicare & Medicaid Services (CMS) on prescription drug costs, showing that pharmacy benefit managers (PBMs) reduce
In case you missed it, former U.S. Representative for Pennsylvania’s 6th Congressional District Ryan Costello discusses how recent legislation targeting pharmacy benefit companies will raise costs for taxpayers and patients and do nothing to address the root cause of high
Welcome to the Pharmacy Benefit Brief. This brief is your monthly snapshot of news from America’s prescription drug supply chain including pharmacy benefit managers, independent pharmacies, and drug manufacturers. Getting the Ball Rolling… The idea that biosimilars,
With so many important issues being debated today, there are few topics that health care, legal, and economic experts agree on. But the fact that drug companies are the root cause of high prescription drug prices is one common denominator
Unlocking an Affordable Future: Key #2 Support and Equip Clinicians SUPPORT AND EQUIP CLINICIANS WITH TOOLS AND DATA TO SERVE PATIENTS OPTIMALLY Physicians, pharmacists, and other health care providers are valued employees within pharmacy benefit companies and esteemed healthcare partners outside
Unlocking an Affordable Future: Key #1 Ensure System Sustainability ENSURE SYSTEM SUSTAINABILITY BY PROMOTING COMPETITION A competitive private market is the best way to manage drug costs. Interventions should be focused on fixing specific market failures or gaps rather than
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today announced a set of industry principles that outline how pharmacy benefit managers, PBMs, interact with employer clients and other prescription drug coverage sponsors to provide clear, transparent contracting and deliver affordable pharmacy
Health care, business, political, and economic experts all agree pharmacy benefit companies deliver significant savings and play a critical role mitigating costs and supporting access to affordable, quality prescription drug coverage for employers and patients. A number of economists, academics,
PBMs Reduce Insulin Costs PBMs are working to improve the lives of patients living with diabetes and their families Insulin prices are high because there are only a few insulin manufacturers, shielded from competition, and those companies set and raise
Pharmacy benefit companies are strong proponents of a highly functioning biosimilar market. Bringing more biosimilars to market, over time, will allow PBMs to more effectively leverage competition to reduce drug costs for health plan sponsors and patients. As biosimilar competition
©2024 PCMA. All Rights Reserved.
